PMGC Holdings Inc. (ELAB) Insider Trading Activity

NASDAQ$1.96+0.02 (1.03%)
Market Cap
$1.57M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
526 of 849
Rank in Industry
303 of 491

ELAB Insider Trading Activity

ELAB Median Price and Trade Amounts History Chart

Statistics of Insider Transactions

Amount of Insider Buys and Sells

Buys
$0
0
–
Sells
$0
0
–

Related Transactions

About PMGC Holdings Inc.

PMGC Holdings Inc. functions as a biopharmaceutical firm, primarily dedicated to sourcing and advancing innovative aesthetic and therapeutic solutions. Its flagship product, EL-22, is a pioneering engineered probiotic designed to tackle the critical challenge of maintaining muscle mass during weight reduction regimens, especially those utilizing GLP-1 receptor agonists. Beyond its core operations, the company also engages in medical scientific research and development and manages various investment firms. Formerly known as Elevai Labs, Inc., …

Insider Activity of PMGC Holdings Inc.

Over the last 12 months, insiders at PMGC Holdings Inc. have bought $0 and sold $0 worth of PMGC Holdings Inc. stock.

On average, over the past 5 years, insiders at PMGC Holdings Inc. have bought $0 and sold $0 worth of stock each year.

There was no buying activity among insiders over the last 12 months.

List of Insider Buy and Sell Transactions, PMGC Holdings Inc.

2005-07-26SalePATTERSON MARK Rdirector
60,000
29.5268%
$31.00
$1.86M
2005-07-26SaleKARP DOUGLAS Mdirector
60,000
29.5268%
$31.00
$1.86M
2005-07-26SaleGRANSEE DAVID HController & Asst. Secretary
46,400
22.8341%
$31.00
$1.44M
2004-08-12SaleGRANSEE DAVID HController & Asst. Secretary
6,400
2.825%
$27.81
$177,958
2004-02-23SaleGRANSEE DAVID HController & Asst. Secretary
6,600
6.1983%
$59.16
$390,456
Total: 5

ELAB Institutional Investors: Active Positions

Increased Positions3+150%1,064+554.17%
Decreased Positions<1-50%46-23.96%
New Positions0New0New
Sold Out Positions<1Sold Out46Sold Out
Total Postitions4+100%1,210+530.21%

ELAB Ownership Change vs Market

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
Tower Research Capital Llc (Trc)$1.000.05%463+248+115.35%2025-09-30
Citigroup Inc$00.02%184+184New2025-09-30
Ubs Group Ag$00.01%117-685-85.41%2025-09-30
Bank Of America Corp /De/$00%4+<1+33.33%2025-09-30
Citadel Advisors Llc$00%0-5,093Sold Out2025-09-30
Sabby Management, Llc$00%0-1,516Sold Out2025-09-30

Financial Ratios

Summary
Comparison with Competitors

Price to Earnings

Price/Earnings to Growth

Price to Sales

Price to Book

Price/Free Cash Flow

Analyst Recommendations

No data is available at this moment.

Analyst Price Targets

No data is available at this moment.
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.